- Home
- CXAIW vs IDYA Comparison
CXAIW vs IDYA Comparison
Compare CXAIW & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CXAIW
- IDYA
- Stock Information
- Founded
- CXAIW N/A
- IDYA 2015
- Country
- CXAIW United States
- IDYA United States
- Employees
- CXAIW 41
- IDYA N/A
- Industry
- CXAIW EDP Services
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- CXAIW Technology
- IDYA Health Care
- Exchange
- CXAIW Nasdaq
- IDYA Nasdaq
- Market Cap
- CXAIW N/A
- IDYA 1.9B
- IPO Year
- CXAIW N/A
- IDYA 2019
- Fundamental
- Price
- CXAIW $0.07
- IDYA $21.92
- Analyst Decision
- CXAIW
- IDYA Strong Buy
- Analyst Count
- CXAIW 0
- IDYA 13
- Target Price
- CXAIW N/A
- IDYA $53.42
- AVG Volume (30 Days)
- CXAIW 20.9K
- IDYA 1.0M
- Earning Date
- CXAIW 03-21-2025
- IDYA 08-05-2025
- Dividend Yield
- CXAIW N/A
- IDYA N/A
- EPS Growth
- CXAIW N/A
- IDYA N/A
- EPS
- CXAIW N/A
- IDYA N/A
- Revenue
- CXAIW $7,200,000.00
- IDYA $7,000,000.00
- Revenue This Year
- CXAIW N/A
- IDYA $101.20
- Revenue Next Year
- CXAIW N/A
- IDYA $286.70
- P/E Ratio
- CXAIW N/A
- IDYA N/A
- Revenue Growth
- CXAIW N/A
- IDYA N/A
- 52 Week Low
- CXAIW $0.11
- IDYA $13.45
- 52 Week High
- CXAIW $0.14
- IDYA $44.42
- Technical
- Relative Strength Index (RSI)
- CXAIW N/A
- IDYA 57.07
- Support Level
- CXAIW N/A
- IDYA $20.50
- Resistance Level
- CXAIW N/A
- IDYA $22.86
- Average True Range (ATR)
- CXAIW 0.00
- IDYA 0.98
- MACD
- CXAIW 0.00
- IDYA -0.17
- Stochastic Oscillator
- CXAIW 0.00
- IDYA 60.09
About CXAIW CXApp Inc. Warrant
CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, and CXAI-VU. The company generates the majority of its revenue from Licenses.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.